|
⚲
|
| Keyboard |
| John Santini | |
|---|---|
| Firm | |
| Address | c/o Vergent Bioscience, Inc 5810 W 78th Street, Suite 222 Minneapolis, MN 55439 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Vergent Bioscience Inc | 021-538478 | Executive Officer | 3.8 M of 5.0 M |
||
| Vergent Bioscience Inc | 021-460613 | Executive Officer | 21.5 M of 22.1 M |
||
| Vergent Bioscience Inc | 021-421974 | Executive Officer | 1.2 M of 2.0 M |
||
| Vergent Bioscience Inc | 021-313696 | Executive Officer | 11.9 M of 11.9 M |
||
| Apogen Biotechnologies Inc | 021-275911 | Director | 7.6 M of 7.6 M |
||
| Radiorx Inc | 021-52568 | Executive Officer | 20.5 M | ||
| Accord Biomaterials Inc | 021-149361 | Director | 1.2 M of 1.2 M |
||
| on Demand Therapeutics Inc | 021-133596 | Director | 0.8 M of 1.6 M |
||
| Microchips Inc | 021-43521 | Executive Officer | 9.2 M of 23.2 M |
||